NURIX THERAPEUTICS, INC. (NRIX) Free cash flow 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$263.5MFY2025 · since FY2019: -$1.1M → -$263.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$263.5M | -44.9% |
| FY2024 | -$181.9M | -102.6% |
| FY2023 | -$89.8M | +47.8% |
| FY2022 | -$172.1M | -91.1% |
| FY2021 | -$90.0M | -1843.1% |
| FY2020 | -$4.6M | -341.2% |
| FY2019 | -$1.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice